logo

For the Inventor, By the Inventor

Ibaraki, Japan

Masazumi Nishikawa

USPTO Granted Patents = 9

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 197(Granted Patents)


Location History:

  • Tsukuba, JP (1996 - 2002)
  • Ibaraki, JP (2003 - 2011)

Company Filing History:

goldMedal5 out of 17 
 
Maruha Corporation
 patents
silverMedal1 out of 24 
 
Taiyo Fishery Co., Ltd.
 patents
bronzeMedal1 out of 3 
 
Maruha Nichiro Seafoods, Inc.
 patents
4. 2 out of 832,912 
Other
 patents

Years Active: 1996-2011

Loading Chart...
9 patents (USPTO):Explore Patents
1. 7906557 - Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether (2011-03-15),
2. 6949553 - Aliphatic compounds, their synthesis method, and utilization of the same (2005-09-27),
3. 6894034 - Sebum production inhibitors (2005-05-17),
4. 6835846 - Aliphatic compounds, process for their preparation and their usage (2004-12-28),
5. 6613897 - Compounds having glucuronic acid derivatives and glucosamine derivative in the structure, process for producing the same and utilization thereof (2003-09-02),
6. 6605705 - Prostaglandin D synthase-specific monoclonal antibody (2003-08-12),
7. 6461827 - Methods and kits for detecting or predicting ischemic disorders (2002-10-08),
8. 6306907 - Antipsychotic (2001-10-23),
9. 5567730 - Method of stabilizing an .omega.-3 unsaturated fatty acid compound (1996-10-22),

Title: The Innovative Journey of Inventor Masazumi Nishikawa

Introduction: Masazumi Nishikawa is an accomplished inventor based in Ibaraki, Japan, known for his significant contributions to the field of innovative therapeutic agents. With 9 patents to his name, he has demonstrated a commitment to developing novel solutions for skin health and circulatory diseases.

Latest Patents: One of his latest inventions is an oral preventive/therapeutic agent for skin damage that contains diacylglyceryl ether as an active ingredient. This formulation is designed to tackle skin damage effectively and is characterized by specific aliphatic hydrocarbon groups. Another major patent revolves around aliphatic compounds, described by an intricate formula that showcases their potential applications in suppressing platelet aggregation, inflammation, and preventing circulatory diseases. These advancements underline his dedication to addressing pressing health concerns through innovative chemistry.

Career Highlights: Throughout his career, Masazumi Nishikawa has been associated with prominent companies, notably Maruha Corporation. His work has led to substantial advancements in therapeutic agents, exhibiting a strong emphasis on research and practical applications. His innovations stand at the intersection of scientific research and real-world health applications.

Collaborations: In his journey, Nishikawa has worked alongside notable professionals such as Tadakazu Tamai and Nobuyuki Sato. These collaborations have enhanced the breadth of his research and have contributed to the successful development of his patented inventions.

Conclusion: Masazumi Nishikawa's impressive portfolio of patents underscores his role as a key innovator in the field of therapeutic agents. His dedication to improving health outcomes through scientific innovation continues to inspire and pave the way for future advancements in the industry. The impact of his work is felt not only in Japan but also in the global arena of health and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…